Overuse of antibiotics around the globe has created a worrying increase in resistance to many commonly used drugs, writes Carl Harald Janson, lead manager on the International Biotechnology trust.
Falling commodities weaken sentiment
The UK healthcare sector is a major beneficiary of EU R&D funding, free-movement of scientists, and a regulatory framework that expedites product approvals across the continent, writes Quilter Cheviot's Amish Patel.
Top position in two funds and trust
Neptune's Chris Taylor analyses the outlook for Japanese equities as the country's central bank looks to provide additional stimulus this month in a bid to help stem the yen's strong run.